Searched for
PARENTERAL DRUGS
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Bio Medica Laboratories IPO: Check GMP, price band, subscription and other detailsBio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...
- Eris Lifesciences shares in focus on move to acquire Swiss Parenterals in Rs 423 crore dealEris Lifesciences is set to fully acquire its injectable unit, Swiss Parenterals. The deal involves a share swap valued at Rs 423.3 crore. ...
- State-owned 'bad bank' acquires three accountsIndia's state-owned 'bad bank,' National Asset Reconstruction Company Ltd (NARCL), has acquired three more accounts in the past two weeks, ...
- PSBs shelve deal to sell drug company loans to NARCLState Bank of India (SBI) and Punjab National Bank (PNB) had given loans to Parenteral Drugs, a contract manufacturer of liquid formulation...
- NARCL offers to buy Rs 1,100 crore loans of Parenteral DrugsNARCL has offered ₹45 crore against a claim of ₹1,173 crore that these two banks have filed with the resolution professional, according to ...
- NCLT approves amalgamation of Lincoln Parenteral & Lincoln PharmaceuticalsAmalgamation of Lincoln Parenteral and Lincoln Pharmaceuticals is expected to bring lots of synergies in terms of operations efficiency, en...
- Bharat Parenterals gets DCGI nod for favipiravir oral suspensionThe company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parente...
- Indian pharma company may sue drug controller over safety of Novartis painkillerNovartis’ Voveran 1ml and Themis' Aquadol have competed with Troikaa’s own injection to manage pain, Dynapar AQ, since their launch in 2013.
- Roselabs Biosciences sets up Rs 400 crore pre-filled syringes unit in AhmedabadCompany claims setting up first fully integrated PFS unit and expects to break-even in next two years, as the demand for PFS is rising.
- Parenteral Drugs to sell unit to Fresenius Kabi for Rs 200 crParenteral Drugs today said its subsidiary, Goa Formulations has entered into an agreement with Fresenius Kabi India to sell its manufactur...
- Dishman acquires Creapharm Parenterals for undisclosed amountDishman Pharma and Chemicals today said its Switzerland-based subsidiary has acquired Creapharm Parenterals for an undisclosed amount.
- Recorded 80% growth in top line: Anil Mittal, Parenteral DrugsIn an interview with ET Now, Anil Mittal, Chief Executive Officer, Parenteral Drugs, talks about the quarterly results and export market.
- Nirma's strategy fails to breathe new life into pharma bizNirma’s attempt to replicate the detergent price war in the pharma segment has not yielded similar results.
- Nirma strategy fails to turn pharma subsidiary aroundIts low-price strategy made it a favourite case study across B-Schools. However, Nirma’s attempt to replicate the detergent price war in th...
- Heard on the Street: Parenteral Drugs soars on bonus share issue buzzSome investors consider a bonus share issue as a signal by companies that their revenues in the coming years are sufficient to service a la...
- Stocks to watch: Reliance MediaWorks, Dr Reddy’s Labs, Spicejet, Radico Khaitan, Shree Cement, Parenteral Drugs, Satyam Computers: Reliance MediaWorks (RMW), which is locked in a takeover battle for multiplex operator Fame with rival Inox, has challenged the sale of m...
Load More
